Krones Refreshes Processing Brand and PET Sterilisation Line as Analysts Split on Recovery

Krones unifies process technology under one brand and unveils a faster Contipure D sterilisation module, as the stock hits a new 52-week low.

Krones has moved on two fronts in quick succession, unveiling a unified brand for its process-technology business and rolling out a faster generation of its aseptic sterilisation module, even as the share price sits near the bottom of its 52-week range.

The Bavarian filling and packaging specialist said on Tuesday that it would consolidate its process-technology activities under the single performance brand "Krones Processing." The offering spans production, processing and preparation along the entire value chain. Existing companies and operating units within the group remain untouched by the reorganisation, according to the company.

A day later, Coca-Cola Europacific Partners Deutschland presented use cases developed jointly with Krones at its Halle site. The project targets unplanned line stoppages and aims to make scheduled maintenance more precise — a priority for bottlers, since every interruption carries direct cost and drags on utilisation.

New sterilisation module promises sharper throughput

Technical work in the core business has continued in parallel. On 28 September Krones introduced the latest generation of its Contipure D module for the aseptic sterilisation of PET preforms. A scalable, multi-level design allows more flexible sterilisation times and a more compact footprint. Depending on the application, the company says output can be raised by as much as 38 percent compared with the previous generation.

Two analysts, two verdicts

September also brought a pair of reassessments from the sell side, pointing in opposite directions. Kepler Cheuvreux lifted the stock to "Hold" from "Reduce" on 28 September, with analyst Hans-Joachim Heimbürger simultaneously removing it from the firm's internal list of least-favoured capital goods names. He cited reduced valuation risk following the earlier share price decline. According to a news agency report, the move brought noticeable relief to trading in the MDAX.

Bernstein Research took a cooler line a few days earlier. On 23 September, analyst Benjamin Thielmann initiated coverage with a "Market-Perform" rating and a price target of 111 euros. He pointed to muted expectations for revenue and order growth in 2027, underpinned by the capital spending plans of beverage producers and bottlers. Customers in the Asia-Pacific growth region in particular, along with general cost pressures, have been holding back on new orders. The analysis house also called into question Krones' own revenue target for 2028 — a stance that weighed on the shares at the time.

A 22 percent slide and a fresh low

The market has made its own judgement clear. Year to date the stock is down 22 percent. On Thursday it touched a new 52-week low of 103.80 euros before steadying slightly, and it closed Friday's session at 105.40 euros.

Attention now turns to how the business actually performed in the third quarter. Krones will publish its quarterly statement for the period to 30 September 2026 on 6 November, followed by a conference call on the results. Only then will investors see how far the reluctance among customers to commit capital has already fed through into the order book and what it has meant for margins.